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Crystal Structure and Ligand Binding Properties
of the D1D2 Region of the Inhibitory
Receptor LIR-1 (ILT2)
I MHC homolog encoded by human cytomegalovirus
(Cosman et al., 1997).
LIR and KIR proteins are members of the immunoglob-
ulin superfamily (IgSF). The extracellular regions contain
four (LIR-1, -2, -3, -4, -6a, -7, -8), three (p70 KIRs), or
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Pasadena, California 91125 two (LIR-5, -6b, and p58 KIRs) IgSF domains (Colonna
and Samaridis, 1995; Wagtmann et al., 1995; Borges et
al., 1997). The first two domains (D1D2) of LIR-1 share
z37% amino acid sequence identity with the corre-
Summary sponding regions of p58 and p70 KIRs; however, the
ligand recognition properties of LIR and KIR proteins
LIR-1 is an inhibitory receptor that recognizes class I differ. The binding site on LIR-1 for class I MHC mole-
MHC molecules and the human cytomegalovirus class cules primarily involves D1 (Chapman et al., 1999),
I homolog UL18. Here, we report the 2.1 A˚ resolution whereas the MHC class I binding site on p58 KIRs in-
crystal structure of the ligand binding portion of LIR-1 cludes D1 and D2 residues in the vicinity of the interdo-
(domains 1 and 2 [D1D2]) and localize the binding re- main hinge (Biassoni et al., 1997; Winter and Long, 1997;
gion for UL18. LIR-1 D1D2 is composed of two immu- Winter et al., 1998; Boyington et al., 2000). In addition,
noglobulin-like domains arranged at an acute angle LIR and KIR proteins bind to different regions of their
to form a bent structure resembling the structures class I MHC ligands. LIR-1 recognizes the relatively non-
of natural killer inhibitory receptors (KIRs). The LIR-1 polymorphic a3 domain of MHC class I molecules
binding site comprises a portion of D1 distant from (Chapman et al., 1999), rationalizing the broad MHC
the interdomain hinge region that constitutes the KIR class I binding specificity (Colonna et al., 1997; Cosman
binding site, consistent with differences in LIR-1 and et al., 1997; Navarro et al., 1999), whereas p58 KIRs
KIR recognition properties and functions. recognize a polymorphic region within the a1-a2 domain
peptide binding region of MHC class I molecules (Lanier,
1998; Boyington et al., 2000), thus explaining the abilityIntroduction
of individual KIRs to distinguish between MHC alleles.
The broad binding specificity of LIR-1 includes recogni-Leukocyte immunoglobulin-like receptor-1 (LIR-1; also
tion of UL18 (Cosman et al., 1997), which shares onlyknown as ILT2 [Samaridis and Colonna, 1997]) is a mem-
z25% sequence identity with classical MHC class I mol-ber of a family of immunoreceptors expressed on mono-
ecules (Beck and Barrell, 1988). In common with LIR-1/cytes, B cells, dendritic cells, and subsets of natural
class I MHC interactions, the primary binding epitopeskiller (NK) and T cells (Borges et al., 1997; Colonna et
are LIR-1 D1 and the UL18 a3 domain (Chapman et al.,al., 1997; Fanger et al., 1998). The LIR family comprises
1999).eight closely related human proteins sharing 63% to
Here, we report the crystal structure and ligand bind-84% sequence identity with LIR-1 (Borges et al., 1997).
ing site of a LIR-1 fragment (LIR-1 D1D2) analogous toBased on functional assays (Colonna et al., 1997) and
the extracellular regions of p58 KIRs. We find that LIR-1the presence of immunoreceptor tyrosine-based inhibi-
D1D2 is structurally similar to p58 KIRs but that it utilizestory motifs (ITIMs) in the cytoplasmic domains of LIR-1,
a different ligand binding surface. These results are dis--2, -3, -5, and -8 (Borges et al., 1997), LIR proteins are
cussed in light of the distinct functions of LIR and KIRpostulated to serve as inhibitory receptors, analogous
family proteins.to killer inhibitory receptors (KIRs) on human NK cells.
KIRs recognize class I MHC molecules on target cells,
thereby inhibiting activating signals delivered by NK ac- Results
tivatory receptors and preventing NK-mediated lysis
(Lanier, 1998). Class I MHC proteins are highly polymor- Crystal Structure of LIR-1 D1D2
LIR-1 D1D2 binds to UL18 and class I MHC proteins withphic within the human population, and individual KIRs
show allele specificity in ligand binding (Lanier, 1998). the same binding affinity as the full-length extracellular
region (Chapman et al., 1999). The crystal structure ofRecognition of class I MHC molecules has also been
demonstrated for LIR-1 and LIR-2, but each LIR protein LIR-1 D1D2 was determined in space group P41212 to
2.1 A˚ resolution and in space group P21 to 3.8 A˚ resolu-binds to a broad range of classical and nonclassical
MHC class I proteins (Colonna et al., 1997; Fanger et tion (Table 1). LIR-1 D1D2 consists of two tandem Ig-
like domains that form a bent structure with an acuteal., 1998; Lanier, 1998; Chapman et al., 1999; Navarro
et al., 1999). In addition, LIR-1 recognizes UL18, a class interdomain angle (Figure 1A). Both domains are primar-
ily composed of b structure arranged into two antiparal-
lel b sheets with a KIR-like folding topology (Figure 1B).
Similar to KIR domains, the first b strand of each LIR-1‡ To whom correspondence should be addressed (e-mail: bjorkman@
domain is shared between the b sheets, such that thecaltech.edu).
strand A region pairs with strand B on one sheet and§ Present address: Department of Chemistry and Biochemistry, Uni-
versity of California, San Diego, California 92093. the A9 region pairs with strand G on the other sheet
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Figure 1. LIR-1 D1D2 Crystal Structure
(A) Ribbon diagram of the structure of LIR-1 D1D2. Disulfide bonds are shown in yellow, and dashed lines indicate disordered loops. Arrow
indicates the location of the bond between residues 99 and 100, which can be proteolitically cleaved to generate stable fragments corresponding
to D1 and D2 (Chapman et al., 1999).
(B) Topology diagram of LIR-1 D1D2. b strands are blue, 310 helices are green, and polyproline type II helices are red.
(C) Stereoview of LIR-1 D1 (green) superimposed upon KIR2DL1 (Fan et al., 1997) (red). N and C termini of LIR-1 D1D2 are labeled. Ca atoms
of the D1 domains of each structure were superimposed, illustrating the slight displacement of the D2 domains. Root mean square deviation
(r.m.s.d) values for superpositions: 0.92 A˚ (71 Ca atoms) (LIR-1 D1 and KIR2DL1 D1), 1.25 A˚ (88 Ca atoms) (LIR-1 D2 and KIR2DL1 D2), 1.36
A˚ (67 Ca atoms) (LIR-1 D1 and LIR-1 D2).
(D) LIR-1 D1D2 model in the region of the D1 310 helix superimposed on a 2.1 A˚ 2jFobsj 2 jFcalcj annealed omit electron density map contoured
at 1.0s (map radius, 3.5 A˚).
(Figures 1A and 1B). In LIR-1, KIR (Fan et al., 1997; loop, which contains a variation of the WSXWS se-
quence motif of hematopoietic receptors (Bazan, 1990)Maenaka et al., 1999; Snyder et al., 1999), and some Fc
receptor domains (Garman et al., 1998; Maxwell et al., (RSESS in LIR-1 D1; WSLPS in LIR-1 D2). As also found
in cytokine receptors (de Vos et al., 1992; Somers et al.,1999; Sondermann et al., 1999), the A to A9 strand switch
is centered at a proline in the cis conformation (Pro12 1994; Livnah et al., 1996; Bravo et al., 1998), KIRs (Fan
et al., 1997; Maenaka et al., 1999; Snyder et al., 1999),in LIR-1 D1, Pro108 in LIR-1 D2).
LIR-1 D1 and D2 include helical regions intermixed and fibronectin III repeats (Huber et al., 1994), the nitro-
gen and side chain hydroxyls of serines in positions nwith the b structure, some of which are not found in KIR
or other IgSF domains (Figures 1A and 1B). Unlike KIR and n 1 3 hydrogen bond with the main chain of strand
F. In the D2 region, Ser-186 and Ser-189 make hydrogenand Fc receptor domains, strand C9 in LIR-1 D1 is re-
placed by residues that display the internal hydrogen bonds with strand F, causing a protrusion of the region
between the serines into the interface between D1bonding pattern of a 310 helix. This helical region is inter-
rupted by a proline at position 51. In the corresponding and D2.
region of D2, the N-terminal portion of the strand C9
region is preserved as a b strand, but the C-terminal The LIR-1 Interdomain Interface
Since a total of three independent views of LIR-1 D1D2portion includes one turn of a 310 helix. Short regions of
310 helix are also found in a loop between the E and F were obtained from analyses of two crystal forms, we
can assess the degree to which the LIR-1 interdomainstrands in D1 and between the F and G strands in D2.
Another secondary structural element found in both angle varies and compare the results to analyses of the
KIR structures. Interdomain angles of 908, 858, and 848LIR-1 domains is a polyproline II type helix, a left-handed
helix characterized by a three residue repeat and phi, were determined (see Experimental Procedures) from
the single LIR-1 D1D2 molecule in the tetragonal crystalpsi angles near –758, 1458 (Adzhubei and Sternberg,
1993). The polyproline II helices are located in the F-G form and from the two D1D2 molecules in the monoclinic
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Table 1. Data Collection and Refinement Statistics for LIR-1 D1D2
Space Group P41212 Space Group P21
Unit cell dimensions (A˚) 68.3, 68.3, Unit cell dimensions (A˚) 35.9, 103.9,
129.7 59.9,
b 5 93.78
Data Collection Data Collection
Resolution 30–2.0 Resolution 30–3.8
Unique reflections 21555 (2112) Unique reflections 4367 (379)
Redundancy 3.6 (3.5) Redundancy 2.3 (2.2)
aCompleteness (%) 99.5 (99.5) aCompleteness (%) 86 (84.5)
I/sI 18.8 (3.6) I/sI 11.6 (5.3)
bRmerge (%) 6.0 (29.7) bRmerge (%) 7.9 (16.1)
Refinement Refinement
Resolution (A˚) 20–2.1 Resolution (A˚) 20–3.8
Work reflections 17642 Work reflections 3622
Test reflections 900 (4.8%) Test reflections 323 (7.4%)
cRcryst (%) 21.3 cRcryst (%) 30.6
dRfree (%) 24.2 dRfree (%) 38.4
Number of atoms Number of atoms
Protein 1513 Protein 2998
(194 of 200 residues)
Water 245
Average B factor 29.1 A˚2 Average B factor 65.7 A˚2
Anisotropic B correction Anisotropic B correction
B11 5 B22 5 21.32 A˚2, B33 5 2.65 A˚2 B11 5 18.44 A˚2, B22 5 9.75 A˚2, B33 5
228.19 A˚2, B13 5 12.25 A˚2
Model geometry
Rms deviations from ideal:
bond lengths (A˚) 0.005
bond angles (deg) 1.4
Ramachandran plot quality:
most favored 91.6%
additionally allowed 7.7%
generously allowed 0.0%
disallowed 0.6%
a Completeness 5 (number of independent reflections)/total theoretical number.
b Rmerge (I) 5 (SjI(i) 2 ,I(h).j/SI(i)), where I(i) is the ith observation of the intensity of the hkl reflection and ,I. is the mean intensity from
multiple measurements of the h,k,l reflection.
c Rcryst (F) 5 ShjjFobs(h)j 2 jFcalc(h)jj/ShjFobs(h)j, where jFobs(h)j and jFcalc(h)j are the observed and calculated structure factor amplitudes for the
h,k,l reflection.
d Rfree is calculated over reflections in a test set not included in atomic refinement.
crystal form. Interdomain angles were measured as 608, contribute 31% of the total buried surface area. Trp-185
is part of the WSXWS sequence motif within the F-G708, and 808 for KIR2DL1, KIR2DL3, and KIR2DL2, re-
spectively (Fan et al., 1997; Maenaka et al., 1999; Snyder loop of D2.
We previously predicted that the LIR-1 extracellularet al., 1999), and 818 and 858 for independent KIR2DL2
molecules in a KIR/class I MHC complex structure (Boy- region would form an extended structure without exten-
sive interactions between domains, based upon the sta-ington et al., 2000). Thus, the LIR-1 D1D2 interdomain
angle falls within the higher limits of the range of angles bility of isolated LIR-1 domains (Chapman et al., 1999).
However, the ability to proteolyze LIR-1 D1D2 into stableseen in KIR structures.
The domain interface between LIR-1 D1D2 is formed fragments (residues 1–99 and 100–197) corresponding
approximately to D1 and D2 (Chapman et al., 1999) canby interactions between the E-F loop and strand G re-
gions of D1 with the F-G loop of D2 and the connecting be accounted for by accessibility of the bond between
residues 99 and 100 (Figure 1A) and interspersed hydro-region between D1 and D2 (G-A loop) (Figures 2 and 3).
A total of 1245 A˚2 of accessible surface area is buried philic residues at the D1D2 interface (Figure 2B).
at the interdomain interface, compared to values of
919 A˚2 to 1076 A˚2 calculated for KIR structures (Fan et Structural Predictions for LIR-1 D1-D4 and Other
LIR Family Membersal., 1997; Maenaka et al., 1999; Snyder et al., 1999). Of
the 13 residues involved in the LIR-1 D1D2 interdomain The significant sequence identities relating individual
LIR-1 domains to each other (25%–44%) and LIR-1 tointeraction (Figure 3), most are hydrophobic (Ala-70, Val-
94, Val-95, Thr-96, Gly-97, and Ala-98 from D1, and Tyr- other LIR family members (63%–84%) (Figures 2A and
2B) suggest that the remaining LIR-1 domains and the99, Tyr-183, Trp-185, Ser-186, and Leu-187 from D2).
The hydrophobic core formed by interactions between domains in other LIR proteins will fold into tertiary struc-
tures similar to LIR-1 D1 and D2. To address whetherthese residues is likely to stabilize the interdomain angle.
A majority of the interdomain interactions involve two the D1D2 interdomain interfaces of other LIR proteins
are similar to the LIR-1 D1D2 interface, we comparedaromatic residues, Tyr-183 and Trp-185, which together
Immunity
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Figure 2. Sequence Alignments
Numbers refer to LIR-1. Locations of the secondary structural elements in the LIR-1 D1D2 structure are indicated above the sequences.
Residues at the D1D2 interdomain interface that contribute more than 10 A˚2 of buried surface area to the interface are indicated with an
asterisk and are yellow if they are identical in LIR-1 and the compared sequences. (A) Sequence alignment of LIR-1 domains. (B) Sequence
alignment of D1D2 regions of LIR-1 and other LIR proteins.
the sequences of the LIR-1 D1D2 interface residues with acute interdomain angle of D1D2 but D3 and D4 are
oriented approximately parallel to each other to form atheir counterparts in other LIRs (Figure 2B). Six of the
thirteen residues involved in the D1D2 interface are con- slightly longer molecule (125 A˚). In the third model, both
D3 and D4 are approximately parallel to their precedingserved in all members of the LIR family, including Trp-
185 (Figure 2A). The remaining residues show some vari- domains, forming a LIR-1 extracellular region with the
maximum possible length (140 A˚).ability, but most changes are conservative. Thus, all LIR
members are likely to share a common arrangement of
D1 relative to D2. Localization of the UL18 Binding Site on LIR-1
In order to identify candidate binding site residues, weThe structures of entire extracellular regions of LIR-1
and the other LIR proteins will depend on the nature of compared the D1 sequences of LIR-1, which binds UL18
with nM affinity (Chapman et al., 1999), and LIR-2, whichthe D2D3 and D3D4 interfaces. To determine if the D2D3
and D3D4 interfaces of LIR-1 are likely to be similar to shows no detectable binding to cell surface UL18 when
expressed as an Fc fusion protein (Borges et al., 1997).the D1D2 interface, we examined the LIR-1 sequence
(Figure 2A). Of the six residues within the strand G region Solvent exposed residues that differ between the LIR-1
and LIR-2 sequences were considered candidate bind-of D1 that interacts with D2, three are conserved in the
corresponding region of D2 that would interact with D3, ing site residues, and their involvement in binding UL18
was investigated by determining the affinities of site-and the others are conservatively substituted (Figure 3).
In the D4 strand G region, one residue is conserved and directed mutants of LIR-1 and LIR-2 D1D2 proteins. All
proteins migrated in the expected position on a gel filtra-four are conservatively substituted. Three of the five
contact residues within the F-G loop of D2 are conserved tion column, and correct folding for mutants that dis-
played affinities for UL18 that were different from wild-in the corresponding region of D3, including D3 Trp-
284, the counterpart of D2 Trp-185, a critical residue type was verified by circular dichroism analyses (data
not shown).in the D1D2 interface. By contrast, the corresponding
region of D4 does not contain a tryptophan and has only LIR-1 residues were introduced into LIR-2 in an effort
to confer UL18 binding activity upon LIR-2. A biosensor-one residue conserved with the contact residues in D2.
From this information, it appears more likely that D2 and based assay was used to compare the binding of UL18
to the D1D2 regions of wild-type LIR-1 and LIR-2 andD3 would interact in a manner analogous to D1 and D2
than would D3 and D4. In Figure 3, we present three the LIR-2 mutants (Figure 4). Wild-type LIR-1 D1D2 binds
to UL18 with an equilibrium dissociation constant (KD)possible models for the structure of the extracellular
region of LIR-1. In the first, the D2D3 and D3D4 inter- of z2 nM, as compared to z12 mM for LIR-2 D1D2
(Figures 4A and 4B). Substitution of LIR-2 residues Gln-faces are modeled upon the D1D2 interface, forming a
bent rod with a length of z110 A˚. The middle model 76, Arg-80, and Trp-83 with their LIR-1 counterparts
(LIR-2 mutant Q76Y/R80D/W83R) resulted in a z10-foldshows a structure in which the D2D3 interface has the
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Figure 3. Hypothetical Models for the Struc-
ture of the LIR-1 Extracellular Region (D1-D4)
(A) Sequences of regions in D1 and D2 that
are involved in the D1D2 interface are shown
with residues contributing more than 10 A˚2 of
buried surface area indicated in yellow boxes.
Sequences of the counterpart regions in the
other LIR-1 domains are shown with boxes
around residues corresponding to D1D2 in-
terface residues with conserved residues in
yellow and chemically similar residues in
green.
(B) Possible structures for the extracellular
region of LIR-1. Approximate lengths of each
model are indicated below its structure. The
model on the left assumes all interfaces re-
semble the D1D2 interface and was con-
structed as follows: D1 of a D1D2 molecule
was aligned on D2 and the position of the D2
domain of the aligned molecule was assigned
as D3. D1 of a D1D2 molecule was then
aligned on the model for D3, and the position
of the D2 domain of the aligned molecule was
assigned as D4. The middle model assumes
that only the D2D3 interface resembles the
D1D2 interface and was constructed follow-
ing the procedure for the left model, except
that the modeled D4 domain was positioned
with its long axis roughly parallel to the long
axis of the LIR-1 extracellular region. The
model on the right assumes that D3 and D4
are both oriented approximately parallel to
the long axis of the LIR-1 extracellular region.
increased binding affinity for UL18. Substitution of LIR-2 D1D2 mutants. We found that mutation of Tyr-38 (LIR-1
mutant Y38A) resulted in an z18-fold reduction in UL18residues 29 and 30 (LIR-2 mutant S29G/L30Q) had no
effect on the binding affinity for UL18. A composite mu- binding affinity (Figure 4F), whereas substitution of resi-
dues 36, 40, 41, 48, 49, 52, 53, and 74 resulted in proteinstant containing all five substitutions (Q76Y/R80D/W83R/
S29G/L30Q) bound to UL18 with approximately the that bound to UL18 without significantly altered affinities
(Table 2). The residues implicated in UL18 binding (Tyr-same affinity as the Q76Y/R80D/W83R mutant, confirm-
ing that substitution of LIR-2 residues 76, 80, and/or 38 and one or more of Tyr-76, Asp-80, and Arg-84) are
indicated on the LIR-1 D1D2 structure in Figure 5A. The83 with their LIR-1 counterparts increases the binding
affinity for UL18 (Figure 4A). residues cluster on the N-terminal end of the A9CC9FG
face of the D1 domain in an area distant from the D1D2In order to confirm the involvement of the LIR-1 coun-
terparts of LIR-2 residues 76, 80, and/or 83 (LIR-1 resi- linker region that contacts MHC class I molecules in
KIRs (Biassoni et al., 1997; Winter and Long, 1997; Vales-dues 76, 80, and 84) in binding UL18, we examined the
effects of changing these and nearby residues in LIR-1 Gomez et al., 1998; Winter et al., 1998; Boyington et al.,
2000) (Figure 5B). To verify that the LIR-1 and KIR bind-D1D2. Alanine substitutions were introduced to make
the LIR-1 mutant Y76A/D80A/R84A, which bound to ing sites are different, we mutated LIR-1 residues that
correspond to KIR residues at the binding site for MHCUL18 with an z20-fold reduced affinity compared with
wild-type LIR-1 D1D2 (Figure 4C; Table 2). Consistent class I molecules. The LIR-1 mutants K42A/T43A and
N180A show wild-type binding affinity for UL18, whereaswith the LIR-2 mutagenesis results, we found no effect
on UL18 binding affinity when LIR-1 residues 29 and 30 substitution of KIR2DL2 residue 44 (the counterpart of
LIR-1 residue 42) greatly reduces the binding affinity forwere changed (LIR-1 mutant G29A/Q30A) (Figure 4D).
The combined mutant (LIR-1 Y76A/D80A/R84A/G29A/ MHC class I molecules (Winter et al., 1998; Boyington
et al., 2000).Q30A) (Figure 4E) showed an z20-fold reduction in UL18
binding affinity compared with wild-type LIR-1 D1D2, In both crystal forms of LIR-1 D1D2, the region that
was identified as the UL18 binding site is involved in aagain demonstrating the involvement of LIR-1 residues
Tyr-76, Asp-80, and/or Arg-84 in the binding site for crystal contact with another D1D2 protein. In the P21
crystals, the two molecules in the asymmetric unit areUL18. Using the crystal structure of LIR-1 D1D2, we
identified solvent exposed residues in the vicinity of related by approximate 2-fold symmetry and are ori-
ented such that the N-terminal end of the A9CC9FG faceresidues 76, 80 and 84 and constructed additional LIR-1
Immunity
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Figure 4. Biosensor Analyses of UL18 Binding to LIR-1 D1D2, LIR-2 D1D2, LIR-1, and LIR-2 Mutants
(A) Wild-type and mutant LIR-2 proteins analyzed using an equilibrium-based approach. Plot shows the percent bound (normalized equilibrium
binding response [Req])versus the log of concentration of the indicated proteins. Derived KD values are approximate because binding is not
saturated at the highest concentration of protein possible to achieve, given the tendency of LIR-2 proteins to aggregate at high concentrations.
(B–F) Sensorgrams (thick colored lines) from kinetics-based binding experiments overlaid with the calculated response (thin black lines)
derived using a 1:1 binding model. In each panel, the injected protein is indicated in front of an arrow pointing to the immobilized protein.
One representative set of injections from experiments performed in triplicate is shown for each interaction (analyses from triplicate experiments
reported in Table 1).
in domain 1 contacts the same surface on the second Discussion
molecule. This contact buries a total of z870 A˚2 of acces-
Here, we report the crystal structure and ligand bindingsible surface area, compared with an average of 570 A˚2
site of the first two domains of LIR-1, a monocyte, mac-total surface area buried in nonspecific crystal contacts
rophage, and dendritic cell inhibitory receptor related(Janin, 1997). The same interaction is present in the
to NK cell KIRs (Borges et al., 1997; Colonna et al., 1997;P41212 crystals, in this case involving two molecules
Cosman et al., 1997; Fanger et al., 1998). LIR-1 D1D2related by a crystallographic 2-fold and burying a total
consists of two IgSF domains that include more helicalsolvent accessible area of 810 A˚2. LIR-1 binds to UL18
structure than generally found in such domains but oth-with 1:1 stoichiometry (Chapman et al., 1999), sug-
erwise bear a close resemblance to the structures ofgesting that the crystallographically observed dimers
KIR domains (Figure 1C). Like KIR domains, the LIR-1are not relevant for ligand binding. However, the obser-
D1 and D2 domains meet at an acute angle to form anvation of an extensive interface involving the region of
interface involving the D1 to D2 connecting region, andD1 identified as the UL18 binding site demonstrates that
sections including the D1 strand E to F loop, D1 strandthis surface has features favorable for protein–protein
G, and the strand F to G loop in D2. Because of the highinteractions and is therefore utilized both for crystal
packing and ligand binding. degree of identity shared between LIR family members
LIR-1 D1D2 Structure and Ligand Binding Site
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Table 2. Biosensor Analyses of UL18 Binding to LIR-1 D1D2, LIR-2 D1D2, LIR-1, and LIR-2 Mutants
Wild-Type or Mutant LIR-2 D1D2 ! UL18 UL18 ! Wild-Type or Mutant LIR-2 D1D2
KD (mM) KD (mM)
LIR-2 D1D2 ! UL18 z14 UL18 ! LIR-2 D1D2 z12
LIR-2 S29G/L30Q ! UL18 z10 UL18 ! LIR-2 S29G/L30Q z9
LIR-2 Q76Y/R80D/W83R ! UL18 z0.5 UL18 ! LIR-2 Q76Y/R80D/W83R z1
LIR-2 S29G/L30Q/Q76Y z1 UL18 ! LIR-2 S29G/L30Q z1
R80D/W83R ! UL18 Q76Y/R80D/W83R
Wild-Type or Mutant LIR-1 D1D2 ! UL18
KD (nM) ka (sec21M21) kd (sec21)
wt D1D2 ! UL18 2.1 6 0.6 (1.4 6 0.2) 3 106 (2.8 6 0.4) 3 1023
G29A/Q30A ! UL18 3.5 6 0.6 (8.6 6 1) 3 105 (2.9 6 0.1) 3 1023
R36A ! UL18 3.3 6 1 (1.4 6 1) 3 106 (4.6 6 0.1) 3 1023
E40A/K41A ! UL18 1.6 6 0.7 (3.1 6 0.1) 3 106 (5.1 6 0.3) 3 1023
K42A/T43A ! UL18 1.2 6 2 (1.5 6 0.3) 3 106 (1.8 6 0.1) 3 1023
T48A/R49A ! UL18 2.4 6 0.7 (1.5 6 0.6) 3 106 (3.6 6 0.1) 3 1023
Q52A/E53A ! UL18 2.9 6 0.7 (1.3 6 0.1) 3 106 (3.7 6 0.5) 3 1023
R74A ! UL18 1.3 6 1 (3.0 6 2) 3 106 (3.8 6 0.4) 3 1023
N180A ! UL18 2.4 6 0.8 (2.1 6 0.2) 3 106 (5.0 6 0.5) 3 1023
Y76A/D80A/R84A ! UL18 42 6 1.4 (1.3 6 0.5) 3 106 (5.3 6 0.9) 3 1022
G29A/Q30A/Y76A/D80A/R84A ! UL18 43 6 2.5 (1.4 6 1.4) 3 106 (6.0 6 0.1) 3 1022
Y38A ! UL18 37 6 1 (1.5 6 0.3) 3 106 (5.6 6 0.6) 3 1022
The injected protein is indicated in front of an arrow pointing to the immobilized protein. When kinetic constants (ka and kd) are reported, the
binding data were fit to a 1:1 binding model, and the KD was determined as kd/ka. KDs were determined from at least three independent
measurements, and the numbers after the 6 sign represent standard deviations. When no kinetic constants are reported, the KD was determined
from equilibrium binding data fit to a 1:1 binding model. Due to the tendency of LIR-2 D1D2 and LIR-2 D1D2 to aggregate at high concentrations,
the highest concentration used was 20 mM, which was not sufficient to saturate binding; thus, the KD values for LIR-1 binding to class I
molecules are approximate.
(Borges et al., 1997) (Figure 2B), the LIR-1 D1D2 struc- are reversed from those observed in the LIR-1 and KIR
structures, such that the D1 domains are located onture can be used as a first-order model for the structures
of other LIR proteins. opposite sides of D2 (Garman et al., 1998; Maxwell et
al., 1999; Sondermann et al., 1999). Despite this differ-We used site directed mutagenesis to identify resi-
dues that contribute to the LIR-1 interaction with UL18, ence, the ligand binding sites in the FceRI and FcgRII
proteins are located at the D1D2 hinge region (Garmana viral class I MHC homolog. Substitutions that affected
the affinity between LIR-1 D1D2 and UL18 mapped to et al., 1998; Sondermann et al., 2000), as also seen in
KIRs (Biassoni et al., 1997; Winter and Long, 1997; Vales-A9CC9FG face of the D1 domain, in a region distant from
the MHC class I binding site on KIRs, which involves Gomez et al., 1998; Winter et al., 1998; Boyington et
al., 2000). By contrast, another two-domain IgSF familyresidues from D1 and D2 that cluster near the interdo-
main hinge (Biassoni et al., 1997; Winter and Long, 1997; member, the Fc receptor for IgA (FcaR), shows different
ligand binding properties. FcaR shares 35%–40% se-Vales-Gomez et al., 1998; Winter et al., 1998; Boyington
et al., 2000). Because the affinity of LIR-1 for class I quence identity with LIR and KIR proteins, compared
with only z20% with the other tandem IgSF domain FcMHC proteins is much lower than for UL18, we were
unable to derive accurate affinities for the binding of the receptors (Wines et al., 1999). Site directed mutagenesis
results mapped onto a homology based model of FcaRLIR-1 and LIR-2 mutants to class I molecules. However,
since LIR-1 recognition of class I MHC proteins and suggest the ligand binding site is located in a region
analogous to the LIR-1 binding site (Wines et al., 1999).UL18 shares common features (i.e., the LIR-1/UL18 and
LIR-1/class I MHC interactions both primarily involve Thus, within the family of proteins containing IgSF do-
mains related by an acute angle, different surfacesthe LIR-1 D1 domain and the a3 domain of UL18 or class
I proteins (Chapman et al., 1999)), it is possible that the within a similar overall structure are utilized for ligand
recognition.LIR-1 binding site for class I proteins will also involve
the region identified as the UL18 binding site. The results reported here illustrate the versatility of
recognition properties of immune system members ofMany of the features of the LIR-1 D1D2 and KIR struc-
tures are also found in the structures of Fc receptors the IgSF and further demonstrate the distinctions be-
tween the LIR and KIR families of inhibitory receptors. Ofsuch as FceRI (Garman et al., 1998), the high-affinity
receptor for IgE, and in FcgRIIa (Sondermann et al., the LIR proteins, only LIR-1 and LIR-2 show detectable
binding to class I MHC molecules (Borges et al., 1997;1999) and FcgRIIb (Maxwell et al., 1999), low-affinity
receptors for IgG. These Fc receptors each contain two Colonna et al., 1998). Ligands for LIR-3 through LIR-8
have not yet been identified. The structure of LIR-1 D1D2IgSF domains related by interdomain hinge angles
slightly more acute than the 608–858 angles observed in and information about its binding site will facilitate func-
tional comparisons with other LIR family members asKIR structures (Fan et al., 1997; Maenaka et al., 1999;
Snyder et al., 1999). Although the hinge angles are all information about ligand recognition by other LIR pro-
teins becomes available.acute, the domain positions in the Fc receptor structures
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Figure 5. Comparison of Ligand Binding
Sites on LIR-1 D1D2 and KIR2DL1
(A) Residues altered by site-directed muta-
genesis are highlighted on a ribbon diagram
of the LIR-1 D1D2 structure. Alteration of resi-
dues indicated in red resulted in changes in
the affinity of LIR-1 D1D2 or LIR-2 D1D2 for
UL18 (Table 2). Alteration of residues indi-
cated in blue had no significant effect on the
binding affinity.
(B) Residues contributing to the KIR binding
site for class I MHC molecules (Biassoni et al.,
1997; Winter and Long, 1997; Vales-Gomez et
al., 1998; Winter et al., 1998; Boyington et
al., 2000) are highlighted on the structure of
KIR2DL1 (Fan et al., 1997).
Experimental Procedures the Stanford Synchrotron Radiation Laboratory beamline 9–2 (l 5
1.000 A˚). A second D1D2 crystal form was grown in 12% PEG 2000,
5% 2-methyl-2–4-pentanediol (MPD), 0.1 M MES (pH 6.0) and cryo-Protein Expression and Characterization
LIR-1 D1D2 and LIR-2 D1D2 (an initial methionine plus residues preserved in a solution containing 20% MPD. These crystals (space
group P21; a 5 35.9 A˚, b 5 103.9 A˚, c 5 59.9 A˚, b 5 93.88) diffract1–197 of the mature protein) were expressed in E. coli strain
BL21(DE3)pLysS and refolded from insoluble inclusion bodies as to 3.8 A˚ resolution and have two molecules per asymmetric unit.
Data were collected at 21508C from a single P21 crystal using anpreviously described (Chapman et al., 1999). Renatured protein was
purified by gel filtration using a Superdex 200 26/60 column (Phar- R-AXIS IV mounted on a Rigaku RU-200 rotating anode generator
(l 5 1.54 A˚). Data were processed and scaled using DENZO andmacia). The N-terminal sequence of purified LIR-1 D1D2 was
GHLPKPTLWAE (data not shown); thus, the methionine residue SCALEPACK (Otwinowski and Minor, 1997).
added to allow production in E. coli was lost. Site directed mutations
were introduced into LIR-1 and LIR-2 using a QuikChange site- Structure Solution, Refinement, and Analysis
directed mutagenesis kit (Stratagene), and mutant proteins were The structure for the P41212 crystal form was determined by molecu-
expressed and purified following the procedure established for wild- lar replacement using AmoRe (Navaza, 1994). The 1.7 A˚ structure
type LIR-1 D1D2 (Chapman et al., 1999). of KIR2DL1 (Fan et al., 1997) (PDB code 1NKR) (nonconserved side
An AVIV 62A DS spectropolarimeter equipped with a thermoelec- chains truncated to alanine and residues 1–6, 54–59 and 80–91
tric cell holder was used for circular dichroism measurements. omitted) was used as a search model. D2 was first located (correla-
Wavelength scans and thermal denaturation curves were obtained tion coefficient: 34.1%; R factor of 52.3%). D1 was then found in a
from 10 mM solutions of wild-type or mutant LIR-1 D1D2 and LIR-2 rotation and translation function in which D2 was fixed (correlation
D1D2 in 5 mM phosphate (pH 7) as described (Chapman et al., coefficient for D1 and D2: 41.8%; R factor of 49.0%). Rigid body
1999). refinement (20–4 A˚) resulted in an Rcryst of 52.1% (Rfree 5 48.3%).
Solvent-flattened maps calculated to 3.0 A˚ were used for initial
rebuilding. Anisotropy and bulk solvent corrections were applied,Crystallization, Data Collection, and Processing
Crystals of LIR-1 D1D2 were grown at 228C in 1:1 hanging drops and the model was refined (20–2.1 A˚) using individual temperature
(B) factors with CNS (Bru¨nger et al., 1998). Residues at the N andcontaining D1D2 (8 mg/mL), 0.7 M potassium sodium tartrate, and
0.1 M Tris chloride (pH 8.5). Single crystals were transferred to a C terminus of the fragment (1 and 199–200) and within two loops
(30–31 and 138–140) are not seen in the electron density and werecryprotectant containing 20% ethylene glycol prior to data collec-
tion. The crystals belong to the tetragonal space group P41212 (a 5 omitted from the model, and side chains for residues 2, 86, 141, and
143 are disordered. Disulfide bonds are found between cysteines 2668.3 A˚, b 5 68.3 A˚, c 5 129.7 A˚; one molecule per asymmetric unit)
and diffract to 2.1 A˚ resolution. Data were collected at 21508C from and 75, 122 and 174, and 134 and 144. The structure of the P21
crystal form was determined by molecular replacement (Navaza,a single P41212 crystal using a Quantum CCD Research detector at
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1994) using the refined LIR-1 D1D2 structure as a search model. References
Both domains D1D2 were used concurrently, but the angle between
domains was not constrained. The top rotation function (20–3.8 A˚) Adzhubei, A.A., and Sternberg, M.J.E. (1993). Left-handed polypro-
peak for domain 1 yielded a translation function (8–3.8 A˚) solution line II helices commonly occur in globular proteins. J. Mol. Biol. 229,
(correlation coefficient: 31.7%; R factor of 51.5%), the top rotation 472–493.
function (20–3.8 A˚) peak for domains 1 and 2 yielded a translation Bazan, J.F. (1990). Structural design and molecular evolution of
function (8–3.8 A˚) solution (correlation coefficient: 43.8%; R factor a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87,
of 47.7%). Rigid body refinement (20–3.8 A˚) followed by group tem- 6934–6938.
perature (B) factor refinement using CNS (Bru¨nger et al., 1998) re-
Beck, S., and Barrell, B.G. (1988). Human cytomegalovirus encodessulted in an Rcryst of 30.6% and an Rfree of 38.4%. a glycoprotein homologous to MHC class I antigens. Nature 331,For analyses of interdomain angles, contacts, and buried surface
269–272.areas, D1 was defined as residues 1–98 and D2 was defined as
Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C.,residues 99–198, following the structure-based definition of
Sivori, S., Moretta, L., and Moretta, A. (1997). Role of amino acidKIR2DL1 domain boundaries (Fan et al., 1997). Interdomain contact
position 70 in the binding affinity of p50.1 and p58.1 receptors forresidues were defined as residues within 3.6 A˚ of the partner domain
HLA-Cw4 molecules. Eur. J. Immunol. 27, 3095–3099.and identified using CONTACT (CCP4, 1994). Buried surface areas
were calculated using SURFACE (CCP4, 1994) with a 1.4 A˚ probe Borges, L., Hsu, M.L., Fanger, N., Kubin, M., and Cosman, D. (1997).
radius. Interdomain angles were calculated by determining the angle A family of human lymphoid and myeloid Ig-like receptors, some of
between the long axes of adjacent domains, approximated by ellip- which bind to MHC class I molecules. J. Immunol. 159, 5192–5196.
soids calculated from the coordinates using the program Dom_angle Boyington, J.C., Motyka, S.A., Schuck, P., Brooks, A.G., and Sun,
(Su et al., 1998). P.D. (2000). Crystal structure of an NK cell immunoglobulin-like re-
Figures 1, 3, and 5 were made with Molscript (Kraulis, 1991) and ceptor in complex with its class I MHC ligand. Nature 405, 537–543.
Raster3D (Merritt and Murphy, 1994).
Bravo, J., Staunton, D., Heath, J.K., and Jones, E.Y. (1998). Crystal
structure of a cytokine-binding region of gp130. EMBO J. 17, 1665–
Biosensor-Based Affinity Measurements 1674.
A Biacore 2000 biosensor system (Pharmacia LKB Biotechnology)
Bru¨nger, A.T., Adams, P.D., Clore, G.M., Gros, P., Grosse-Kunstleve,was used to determine binding affinities. Samples were purified by
R.W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N.S., Read, R.J.,size exclusion chromatography to minimize the signal resulting from
et al. (1998). Crystallography and NMR system: a new softwareaggregated protein. Binding between a molecule coupled to a bio-
system for macromolecular structure determination. Acta Crys-sensor chip and a second molecule injected over the chip results
tallogr. D 54, 905–921.in changes in the surface plasmon resonance signal that are read
CCP4 (Collaborative Computational Project 4) (1994). The CCP4out in real time as resonance units (RU) (Karlsson and Fa¨lt, 1997).
suite: programs for protein crystallography. Acta. Crystallogr. D 50,Proteins were covalently immobilized at pH 5.5 on a CM5 chip (Phar-
760–763.macia LKB Biotechnology) using standard amine coupling chemistry
as described in the Biacore manual. Samples were injected at room Chapman, T.L., Heikema, A.P., and Bjorkman, P.J. (1999). The inhibi-
temperature in 50 mM PIPES (pH 7.0), 150 mM NaCl, and 0.005% tory receptor LIR-1 uses a common binding interaction to recognize
Biacore surfactant P20. All injections were followed by an identical classical and non-classical class I MHC molecules and the viral
injection onto a mock-coupled flowcell. MHC homolog UL18. Immunity 11, 603–613.
Binding interactions between UL18 and LIR-1 proteins were as- Colonna, M., and Samaridis, J. (1995). Cloning of immunoglobulin-
sayed using short injection times (2–4 min) with fast flow rates (100 superfamily members associated with HLA-C and HLA-B recogni-
ml/min) over biosensor chips coupled to low densities (300 RU) tion by human natural killer cells. Science 268, 405–408.
(kinetics-based approach) to minimize mass transport effects upon
Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis,the kinetics of the binding reactions (Karlsson and Fa¨lt, 1997). Kinetic
J., Angman, L., Cella, M., and Lopez-Botet, M. (1997). A commonconstants were derived from sensorgram data using global fitting
inhibitory receptor for major histocompatibility complex class I mol-of the association and dissociation phases of all curves in the work-
ecules on human lymphoid and myelomonocytic cells. J. Exp. Med.ing set using BIAevaluation version 3.0. Sensorgrams were fit to a
186, 1809–1818.binding model that assumes a single class of noninteracting binding
Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R.L., O’Cal-sites in a 1:1 binding interaction. KD’s were derived from the ratios
laghan, C.A., Dunbar, R., Ogg, G.S., Cerundolo, V., and Rolink, A.of rate constants (ka and kd) as KD 5 kd/ka.
(1998). Human myelomonocytic cells express an inhibitory receptorBinding interactions between UL18 and LIR-2 proteins were as-
for classical and nonclassical MHC class I molecules. J. Immunol.sayed using an equilibrium-based approach that is not affected by
160, 3096–3100.mass transport effects. For these experiments, we used slow flow
rates (5 ml/min) over biosensor chips coupled to high densities Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson,
(1500–2000 RU). The response was measured 10 s after the start L., and Hsu, M.-L. (1997). A novel immunoglobulin superfamily re-
of the injection, and KD’s were derived by nonlinear regression analy- ceptor for cellular and viral MHC class I molecules. Immunity 7,
sis of plots of Req (the equilibrium binding response) versus the log 273–282.
of the injected protein concentration, and the data were fit to a de Vos, A.M., Ultsch, M., and Kossiakoff, A.A. (1992). Human growth
1:1 binding model as described (Vaughn and Bjorkman, 1997). A hormone and extracellular domain of its receptor: crystal structure
previous comparison of the kinetics-based versus equilibrium- of the complex. Science 255, 306–312.
based methods for determining KD’s demonstrated that both meth-
Fan, Q.R., Mosyak, L., Winter, C.C., Wagtmann, N., Long, E.O., andods yielded comparable values for the same binding interaction
Wiley, D.C. (1997). Structure of the inhibitory receptor for human(Lebro´n et al., 1998).
natural killer cells resembles haematopoietic receptors. Nature 389,
96–100.
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